Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Annals of neurology·2026
Same author

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Brain : a journal of neurology·2026
Same author

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

JAMA network open·2026
Same author

Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A case of myelopathy due to HTLV-1 infection.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Related Experiment Video

Updated: May 5, 2026

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

16.0K

Transcription-based prediction of response to IFNbeta using supervised computational methods.

Sergio E Baranzini1, Parvin Mousavi, Jordi Rio

  • 1Department of Neurology, School of Medicine University of California, San Francisco, USA. sebaran@cgl.ucsf.edu <sebaran@cgl.ucsf.edu>

Plos Biology
|January 5, 2005
PubMed
Summary

Predicting multiple sclerosis (MS) treatment response is now possible. Gene expression patterns in peripheral blood mononuclear cells can predict patient response to recombinant human interferon beta (rIFNbeta) therapy with high accuracy.

More Related Videos

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1&#946; using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 2, 2011

25.4K
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

19.4K

Related Experiment Videos

Last Updated: May 5, 2026

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

16.0K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1&#946; using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 2, 2011

25.4K
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

19.4K

Area of Science:

  • Genomics
  • Pharmacogenomics
  • Immunology

Background:

  • Recombinant human interferon beta (rIFNbeta) is a standard treatment for multiple sclerosis (MS) exacerbations.
  • Treatment efficacy is limited by adverse effects and a significant proportion of nonresponders.

Purpose of the Study:

  • To identify predictive gene expression patterns for rIFNbeta treatment response in MS patients.
  • To define the molecular signature of rIFNbeta in peripheral blood mononuclear cells (PBMCs).

Main Methods:

  • Applied data-mining and predictive modeling to a 70-gene expression dataset from 52 MS patients.
  • Utilized longitudinal kinetic reverse-transcription PCR (RT-PCR) to analyze gene expression profiles.
  • Performed time-series analysis to identify key players in treatment response.

Main Results:

  • Identified nine gene triplets whose pre-treatment expression predicts rIFNbeta response with up to 86% accuracy.
  • Revealed potential key molecular players associated with good or poor treatment outcomes.
  • Established the robustness of predictive models through statistical testing.

Conclusions:

  • Pre-existing gene expression signatures in PBMCs can predict rIFNbeta response in MS patients.
  • Kinetic RT-PCR and data-mining are effective tools for discovering gene expression signatures related to therapeutic effects.
  • This approach may lead to personalized treatment strategies for MS.